Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
Clinical trial NCT06351891 · UNKNOWN
Trial details
- NCT number
- NCT06351891
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-12-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.